Alimera Sciences Q4 EPS $(0.07) Up From $(0.54) YoY, Sales $26.31M Beat $24.34M Estimate
Alimera Sciences Q4 EPS $(0.07) Up From $(0.54) YoY, Sales $26.31M Beat $24.34M Estimate
Alimera Sciences第四季度每股收益美元（0.07美元）高于同比（0.54美元），销售额2631万美元超过预期的2434万美元
Alimera Sciences (NASDAQ:ALIM) reported quarterly losses of $(0.07) per share. This is a 87.04 percent increase over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $26.31 million which beat the analyst consensus estimate of $24.34 million by 8.08 percent. This is a 87.51 percent increase over sales of $14.03 million the same period last year.
Alimera Sciences（纳斯达克股票代码：ALIM）报告称，季度每股亏损为0.07美元。与去年同期每股亏损0.54美元（0.54）相比，增长了87.04％。该公司公布的季度销售额为2631万美元，比分析师普遍预期的2434万美元高出8.08％。这比去年同期的1,403万美元销售额增长了87.51％。